Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 4/2021

20.10.2020 | COVID-19 | Brief Report Zur Zeit gratis

Evaluation of three immunochromatographic tests in COVID-19 serologic diagnosis and their clinical usefulness

verfasst von: Manuela Pegoraro, Valentina Militello, Gian Luca Salvagno, Stefania Gaino, Antonella Bassi, Cecilia Caloi, Angelo Peretti, Silvia Bizzego, Laura Poletto, Chiara Bovo, Giuseppe Lippi, Giuliana Lo Cascio

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 4/2021

Einloggen, um Zugang zu erhalten

Abstract

Results of three rapid immunochromatographic tests (ICTs) were compared with those obtained with two automated immunoassays for evaluation of their usefulness. One hundred fifty-nine patients and 67 healthy volunteers were included. Different assays demonstrate 41–45% of diagnostic sensitivities and 91–98% of specificities, with substantial agreement (89.3–91.2%), but a high percentage of weak positive results (13–22%) was observed with ICTs. ICTs performances were comparable to those of automated immunoassays. ICTs could have a role as screening approach due to their easy usability. Subjective interpretation, significant rate of uncertain results, uncertainty on viral antigens source are undoubtedly drawbacks.
Literatur
1.
Zurück zum Zitat Callaway E (2020) Time to use the p-word? Coronavirus enter dangerous new phase. Nature 579:12CrossRef Callaway E (2020) Time to use the p-word? Coronavirus enter dangerous new phase. Nature 579:12CrossRef
3.
Zurück zum Zitat World Health Organization (2020) Advice on the use of point-of-care immunodiagnostic tests for COVID-19. Sci Brief World Health Organization (2020) Advice on the use of point-of-care immunodiagnostic tests for COVID-19. Sci Brief
4.
Zurück zum Zitat World Health Organization (2020) Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected cases. Interim Guid World Health Organization (2020) Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected cases. Interim Guid
5.
Zurück zum Zitat Li Y, Yao L, Li J, Chen L, Song Y, Cai Z et al (2020) Stability issues of RT-PCR testing of SARS-CoV-2 for hospitalized patients clinically diagnosed with COVID-19. J Med Virol:1–6 Li Y, Yao L, Li J, Chen L, Song Y, Cai Z et al (2020) Stability issues of RT-PCR testing of SARS-CoV-2 for hospitalized patients clinically diagnosed with COVID-19. J Med Virol:1–6
6.
Zurück zum Zitat Pan Y, Li X, Yang G, Fan J, Tang Y, Zhao J et al (2020) Serological immunocromatographic approach in diagnosis with SARS-CoV-2 infected patients. J Infect 2:54 Pan Y, Li X, Yang G, Fan J, Tang Y, Zhao J et al (2020) Serological immunocromatographic approach in diagnosis with SARS-CoV-2 infected patients. J Infect 2:54
7.
Zurück zum Zitat Lippi G, Salvagno GL, Pegoraro M, Militello V, Caloi C, Peretti A et al (2020) Assessment of antibodies to SARS-CoV2 with the fully automated MAGLUMI 2019-nCoV IgG and IgM chemiluminescence immunoassays. Letter to Editor. Clin Chem Lab Med Lippi G, Salvagno GL, Pegoraro M, Militello V, Caloi C, Peretti A et al (2020) Assessment of antibodies to SARS-CoV2 with the fully automated MAGLUMI 2019-nCoV IgG and IgM chemiluminescence immunoassays. Letter to Editor. Clin Chem Lab Med
8.
Zurück zum Zitat Zhao J, Yuan Q, Wang H, Liu W, Liao X, Su Y et al (2020) Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clin Infect Dis Zhao J, Yuan Q, Wang H, Liu W, Liao X, Su Y et al (2020) Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clin Infect Dis
9.
Zurück zum Zitat Infantino M, Damiani A, Li Gobbi F, Grossi V, Lari B, Macchia D et al (2020) Serologica assays for SARS-CoV-2 infectious disease: benefits, limitations andpPerspectives. Isr Med Assoc J 22(4):203–210PubMed Infantino M, Damiani A, Li Gobbi F, Grossi V, Lari B, Macchia D et al (2020) Serologica assays for SARS-CoV-2 infectious disease: benefits, limitations andpPerspectives. Isr Med Assoc J 22(4):203–210PubMed
10.
Zurück zum Zitat Cassaniti I, Novazzi F, Giardina F, Salinaro F, Sachs M, Perlini S et al (2020) Performance of VivaDiag COVID-19 IgM/IgG rapid Ttest is inadequate for diagnosis of COVID-19 in acute patients referring to emergency room department. Letter to Editor. J Med Virol:1–4 Cassaniti I, Novazzi F, Giardina F, Salinaro F, Sachs M, Perlini S et al (2020) Performance of VivaDiag COVID-19 IgM/IgG rapid Ttest is inadequate for diagnosis of COVID-19 in acute patients referring to emergency room department. Letter to Editor. J Med Virol:1–4
Metadaten
Titel
Evaluation of three immunochromatographic tests in COVID-19 serologic diagnosis and their clinical usefulness
verfasst von
Manuela Pegoraro
Valentina Militello
Gian Luca Salvagno
Stefania Gaino
Antonella Bassi
Cecilia Caloi
Angelo Peretti
Silvia Bizzego
Laura Poletto
Chiara Bovo
Giuseppe Lippi
Giuliana Lo Cascio
Publikationsdatum
20.10.2020
Verlag
Springer Berlin Heidelberg
Schlagwort
COVID-19
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 4/2021
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-020-04040-1

Weitere Artikel der Ausgabe 4/2021

European Journal of Clinical Microbiology & Infectious Diseases 4/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.